ThinkSono develops ultrasound AI guidance software called Guidance that enables non-ultrasound trained healthcare staff to scan patients suspected of deep vein thrombosis (DVT) and send data for qualified clinician review. The product aims to improve the clinical pathway for DVT, which the article notes is a leading cause of preventable hospital death worldwide. ThinkSono has partnered with hospitals across Europe, including in the UK, Germany and Greece, and announced strategic partnerships with NYU Langone Health and Temple Health. The company is led by CEO Fouad Al Noor. ThinkSono raised £2.1M in funding and intends to use the proceeds to expand operations and its R&D sector.

Total raised

$3M

Funding rounds

1

Latest round

Equity

Latest activity

Mar 2024